We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image

INDIA AND OMAN PHARMACEUTICAL INDUSTRY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2021 - 2030)

India and Oman Pharmaceutical Industry Market, by Drug (Generic and Patented (Branded)), by Type (Prescription Drugs and Over the Counter Drugs), by Drug Class (Analgesics, Anesthetics, Antibacterials, Antidepressants, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Anticonvulsants, Antivirals, Anticoagulants, ACE inhibitors, Hormonal agents, Insulin, Contraceptives, Diuretics, Vaccines, and Others), by Application (Cardiovascular (Ischemic Heart Disease and Others), Hypertension, Musculoskeletal, Oncology, Anti-infective, Cirrhosis, Metabolic Disorder (Diabetes and Others), Weight Management, Central Nervous System, Genito-urinary, Kidney Disease, Gastrointestinal, Respiratory, Hematology, Dermatology, Ophthalmology, and Others (Nutraceutical, Dentals, and Gynecology)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) and by Country (India and Oman) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • Published In: 11 Aug, 2021
  • Code: CMI4569
  • Page number: 465
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug
      • Market Snapshot, By Type
      • Market Snapshot, By Drug Class
      • Market Snapshot, By Application
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Country
      • Market Opportunity Map
  3. India & Oman Pharmaceutical Industry Market

    • Analysis of the Indian Pharmaceutical Industry

      • Drivers & Restraints
      • Market Opportunity
      • Market Trends
      • Impact Analysis
      • Mergers and Acquisitions
      • Epidemiology
      • PEST Analysis
      • SWOT Analysis
      • Regulatory Scenario
      • Reimbursement Scenario
      • Major Indian Exporters/Manufacturers (Global)
      • Major Indian Importers
      • Major Indian Exporters/Manufacturers (To Oman)
      • Indian Pharmaceutical Drugs Import Market
      • Indian Pharmaceutical Drugs Export Market
        • Indian Pharmaceutical Drugs Export to Oman Market
    • Analysis of the Oman Pharmaceutical Industry

      • Drivers & Restraints
      • Market Opportunity
      • Market Trends
      • Impact Analysis
      • Mergers and Acquisitions
      • Epidemiology
      • PEST Analysis
      • SWOT Analysis
      • Regulatory Scenario
      • Industry Regulations
        • Trade Regulations and Procedures For Export to Oman
        • Trade Barriers (Tariff, Non-tariff, etc.) and Other Entry-level Barriers for Indian Pharma Products in Oman
      • Reimbursement Scenario
      • Major Oman Exporters/Manufacturers (Global)
      • Major Oman Importers
      • Strategy For Indian Pharma Products In Oman
      • India's Strategy For Effectively Entering Oman Pharma Market
      • USP Of Indian Companies In The Oman Pharmaceutical Market And Positioning Strategy
      • Oman Pharmaceutical Drugs Import Market
      • Oman Pharmaceutical Drugs Export Market
        • Oman Pharmaceutical Drugs Export to India Market
      • Ayurvedic Drugs Market
        • Overview of Indian Ayurvedic Drugs
        • Ayurvedic Products by Indian Companies With Certification of Pharmaceutical Product (COPP) Granted As Per WHO-GMP Certification Scheme (1/2)
        • Overview of Oman Ayurvedic Drugs Import
        • Indian Ayurvedic Companies Registered in Oman
      • Strategies Adopted By Local Oman Manufacturers
  4. India & Oman Pharmaceutical Industry Market - Impact of Coronavirus (Covid-19) Pandemic

    • Economic Impact
    • Impact of COVID-19 on Pharmaceutical Market
    • Demand and Supply Chain Analysis
    • Government Initiative
  5. India & Oman Pharmaceutical Industry Market, By Drug, 2011 – 2030 (US$ Million)

    • Introduction
      • Market Share Analysis, 2021 and 2030 (%)
      • Y-o-Y Growth Analysis, 2012 – 2030
      • Segment Trends
    • Generic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Patented (Branded)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
  6. India & Oman Pharmaceutical Industry Market, By Type, 2011 – 2030 (US$ Million)

    • Introduction
      • Market Share Analysis, 2021 and 2030 (%)
      • Y-o-Y Growth Analysis, 2012 – 2030
      • Segment Trends
    • Prescription Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Over the Counter Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million
  7. India & Oman Pharmaceutical Industry Market, By Drug Class, 2011 – 2030 (US$ Million)

    • Introduction
      • Market Share Analysis, 2021 and 2030 (%)
      • Y-o-Y Growth Analysis, 2012 – 2030
      • Segment Trends
    • Analgesics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Anesthetics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Antibacterials
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Antidepressants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Corticosteroids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Anticonvulsants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Antivirals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Anticoagulants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • ACE inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Hormonal agents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Insulin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Contraceptives
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Diuretics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
  8. India & Oman Pharmaceutical Industry Market, By Application, 2011 – 2030 (US$ Million)

    • Introduction
      • Market Share Analysis, 2021 and 2030 (%)
      • Y-o-Y Growth Analysis, 2012 – 2030
      • Segment Trends
    • Cardiovascular
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
      • Ischemic Heart Disease
      • Others
    • Hypertension
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Musculoskeletal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Anti-infective
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Metabolic Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
      • Diabetes
      • Others
    • Weight Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Central Nervous System
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Genito-urinary
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Kidney Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Gastrointestinal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Respiratory
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Hematology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Dermatology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Ophthalmology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Others (Nutraceutical, Dentals, and Gynecology)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
  9. India & Oman Pharmaceutical Industry Market, By Distribution Channel, 2011 – 2030 (US$ Million)

    • Introduction
      • Market Share Analysis, 2021 and 2030 (%)
      • Y-o-Y Growth Analysis, 2012 – 2030
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
  10. India & Oman Pharmaceutical Industry Market, By Country, 2011 – 2030 (US$ Million)

    • Introduction
      • Market Share Analysis, 2021 and 2030 (%)
      • Y-o-Y Growth Analysis, 2012 – 2030
      • Regional Trends
    • India
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2011 – 2030 (US$ Million)
    • Oman
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2011 – 2030 (US$ Million)
  11. Case Study of Successful Foreign Pharma Product Entries Into    Oman Market

    • Case Study of 5 Successful Foreign Pharma Companies Entry Into Oman Market

    • Company Profiles (Global)

      • Pfizer, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Bristol-Myers Squibb Company
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Sanofi S.A.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • F. Hoffmann-La Roche AG
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Bayer AG
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Novartis International AG
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Merck & Co., Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • AbbVie Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • GlaxoSmithKline plc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Eli Lilly and Company
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
    • Company Profiles (India)

      • Zydus Cadila
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Aurobindo Pharma Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Cipla Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Dr. Reddy's Laboratories Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Lupin Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Sun Pharmaceutical Industries Limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Serum Institute of India Pvt. Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Biocon Limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Strides Pharma Science Limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Unichem Laboratories Limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
  12. Section

    • Research Methodology
    • About us

*Browse 89 market data tables and 64 figures on "India & Oman Pharmaceutical Industry Market” – India & Oman forecast to 2030

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.